Other clinical trials in patients with non-Hodgkin's lymphoma [24] and sufferers with Highly developed malignancy [14] have shown also that zosuquidar did not considerably have an affect on the pharmacokinetics of doxorubicin and had average effects to the pharmacokinetics of vincristine. These clinical trials permitted that zosuquidar could safely and https://johnnyy167alx0.governor-wiki.com/user